<DOC>
	<DOCNO>NCT01877551</DOCNO>
	<brief_summary>Rates cardiovascular disease diabetes 2-fold great HIV infect people general population . Protease inhibitor booster antiretroviral therapy ( PI-ART ) use ~50 % HIV infected people USA establish risk factor diabetes . Tauroursodeoxycholic acid ( TUDCA ) , naturally occur bile salt , improve insulin sensitivity HIV uninfected subject , although mechanisms benefit unclear . This study explore hypothesis TUDCA improve insulin action people HIV receive PI-ART . Further , project clarify molecular mechanism responsible improvement potentially benefit society , irrespective HIV status .</brief_summary>
	<brief_title>Tauroursodeoxycholic Acid Protease-inhibitor Associated Insulin Resistance</brief_title>
	<detailed_description>The purpose study determine , mechanism , tauroursodeoxycholic acid improve insulin sensitivity subject protease-inhibitor associated insulin resistance . The investigator perform body composition analysis use DEXA machine , liver fat measurement use MRI , hyperinsulinemic euglycemic clamp procedure 48 HIV infect , insulin-resistant/prediabetic subject 30 day treatment tauroursodeoxycholic acid match placebo . Biopsies adipose tissue skeletal muscle take fasting condition insulin infusion , treatment measure marker endoplasmic reticulum stress thyroid hormone deiodinase . Outcome measure : The primary outcome measure change glucose clearance insulin infusion , change marker endoplasmic reticulum stress change content D2 muscle .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Tauroursodeoxycholic acid</mesh_term>
	<mesh_term>Taurochenodeoxycholic Acid</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<criteria>HIV+ receive protease inhibitor contain antiretroviral therapy &gt; 6 month Undetectable viral load insulin resistant 1. impaired fast glucose ( fast blood glucose &gt; 100mg/dl ) 2. impaired glucose tolerance ( blood glucose &gt; 140mg/dl 2 hour oral glucose tolerance test ) . abstained medication affect glucose ( e.g . prednisone , growth hormone ) stable medication &gt; 3 month weight loss &gt; 5 % body weight prior 6 month active gastrointestinal disease ( gallstone , pancreatitis , hepatitis , diarrhea ) use antidiabetic medication cardiovascular disease ( uncontrolled hypertension , heart attack , heart failure , prior endocarditis ) history active substance abuse blood clot disorder take medication affect blood clotting ( e.g . coumadin , warfarin ) pregnant , plan become pregnant lactate unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Protease inhibitor</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>Tauroursodeoxycholic acid</keyword>
</DOC>